HFA Premium Access

Intramyocardial injections of the continuous erythropoietin receptor activator (CERA) in patients with chronic ischemic cardiomyopathy. Results of the randomized study

Presentation

About the speaker

Mr Denis Losik

National Medical Research Center named after E.N.Meshalkin, Novosibirsk (Russian Federation)
2 presentations
0 follower

13 more presentations in this session

Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.

Speaker: Doctor S. James (Dublin, IE)

Thumbnail

Effects of 5 years treatment with nebivolol, carvedilol and bisoprolol in heart failure patients

Speaker: Doctor G. Marazzi (Rome, IT)

Thumbnail

MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart

Speaker: Doctor B. Stauffer (Aurora, US)

Thumbnail

Is the cohort of paradigm-hf representative of the real world population of patients with systolic heart failure?

Speaker: Doctor G. Rocha Rodrigues (Lisboa, PT)

Thumbnail

Evidence-based medications in multi-ethnic Asian patients with heart failure are associated with better outcomes in spite of lower doses

Speaker: Doctor T. Teng (Singapore, SG)

Thumbnail

Access the full session

Rapid Fire 3 - Chronic heart failure management

Speakers: Mr D. Losik, Doctor S. James, Doctor G. Marazzi, Doctor B. Stauffer, Doctor G. Rocha Rodrigues...
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk